In analyses of EBV‐positive cHL without adjustment for effects of other alleles, HLA‐A*01:01, C*07:01, B*08:01 and DRB1*03:01 were all associated with increased disease risk (Table 3). This evidence concerns the gene HLA-A and classic Hodgkin lymphoma.